Quality of reporting randomized controlled trials in cancer nursing research

Nursing Research

Volumn 63, Issue 1, 2014, Pages 26-35

  Guo, Jia Wen ^a   Sward, Katherine A ^a   Beck, Susan L ^a   Staggers, Nancy ^b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF NURSING   (United States)

Author keywords

cancer; clinical nursing research; CONSORT; randomized controlled trial

Indexed keywords

ARTICLE; HUMAN; METHODOLOGY; NURSING RESEARCH; ONCOLOGY NURSING; PUBLICATION; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARD;

HUMANS; NURSING RESEARCH; ONCOLOGY NURSING; PERIODICALS AS TOPIC; PUBLISHING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REFERENCE STANDARDS; RESEARCH DESIGN;

EID: 84891545090     PISSN: 00296562     EISSN: 15389847     Source Type: Journal    
DOI: 10.1097/NNR.0000000000000007     Document Type: Article

References (36)

1. American Cancer Society. (2012). Cancer facts and figures 2012. Atlanta, GA: Author
2. Begg, C., Cho, M., Eastwood, S., Horton, R., Moher, D., Olkin, I., I Stroup, D. F. (1996). Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA, 276, 637-639
3. Bhandari, M., Richards, R. R., Sprague, S., & Schemitsch, E. H. (2001). Quality in the reporting of randomized trials in surgery: Is the Jadad scale reliablé Controlled Clinical Trials, 22, 687-688
4. Boutron, I., Tubach, F., Giraudeau, B., & Ravaud, P. (2004). Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials. Journal of Clinical Epidemiology, 57, 543-550
5. Camm, C. F., Chen, Y., Sunderland, N., Nagendran, M., Maruthappu, M., & Camm, A. J. (2013). An assessment of the reporting quality of randomised controlled trials relating to antiarrhythmic agents (2002-2011). International Journal of Cardiology, 168, 1393-1396. doi: 10.1016/j.ijcard.2012.12.020
6. Clark, H. D., Wells, G. A., Huët, C.,McAlister, F. A., Salmi, L. R., Fergusson, D., & Laupacis, A. (1999). Assessing the quality of randomized trials: Reliability of the Jadad scale. Controlled Clinical Trials, 20, 448-452
7. CONSORT. (2011). CONSORT endorsers-journals. CONSORT Endorsement. Retrieved from http://www.consort-statement.org/ about-consort/consort- endorsement/consort-endorsers - journals/
8. Dechartres, A., Charles, P., Hopewell, S., Ravaud, P., & Altman, D. G. (2011). Reviews assessing the quality or the reporting of randomized controlled trials are increasing over time but raised questions about how quality is assessed. Journal of Clinical Epidemiology, 64, 136-144
9. Devereaux,P. J.,Choi, P.T. -L.,El-Dika, S.,Bhandari,M.,Montori,V.M., Schünemann,H. J.,IGuyatt,G.H. (2004). An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods. Journal of Clinical Epidemiology, 57, 1232-1236
10. EBSCO Publishing. (2013). CINAHL with full text. Hospitals Medical Institutions. Retrieved September 3, 2013, from http:// www.ebscohost.com/ biomedical-libraries/cinahl-with-full-text
11. Goodfellow, L.M. (2003). The effects of therapeutic back massage on psychophysiologic variables and immune function in spouses of patients with cancer. Nursing Research, 52, 318-328
12. Gupta, S. K. (2011). Intention-to-treat concept: A review. Perspectives in Clinical Research, 2, 109-112
13. Hui, D., Arthur, J., Dalal, S., & Bruera, E. (2012). Quality of the supportive and palliative oncology literature: A focused analysis on randomized controlled trials. Supportive Care in Cancer, 20, 1779-1785
14. Huwiler-Müntener, K., Jüni, P., Junker, C.,&Egger,M. (2002). Quality of reporting of randomized trials as ameasure of methodologic quality. JAMA, 287, 2801-2804
15. Jadad, A. R.,Moore, R.A.,Carroll, D., Jenkinson,C., Reynolds,D. J.M., Gavaghan, D. J., &McQuay, H. J. (1996). Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Controlled Clinical Trials, 17, 1-12
16. Kunz, R., & Oxman, A. D. (1998). The unpredictability paradox: Review of empirical comparisons of randomised and nonrandomised clinical trials. BMJ, 317, 1185-1190
17. Lai, R., Chu, R., Fraumeni, M., & Thabane, L. (2006). Quality of randomized controlled trials reporting in the primary treatment of brain tumors. Journal of Clinical Oncology, 24, 1136-1144
18. Leucht, S., Kissling, W., & Davis, J. M. (2009). How to read and understand and use systematic reviews and meta-analyses. Acta Psychiatrica Scandinavica, 119, 443-450
19. Little, R. J., & Rubin, D. B. (2000). Causal effects in clinical and epidemiological studies via potential outcomes: Concepts and analytical approaches. Annual Review of Public Health, 21, 121-145
20. Mills, E. J., Wu, P., Gagnier, J., & Devereaux, P. J. (2005). The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement. Contemporary Clinical Trials, 26, 480-487
21. Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gotzsche, P. C., Devereaux, P. J., I Altman, D. G. (2010). CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials. Journal of Clinical Epidemiology, 63, e1Ye37
22. Moher, D., Jones, A., & Lepage, L. (2001). Use of the CONSORT statement and quality of reports of randomized trials: A comparative before-and-after evaluation. JAMA, 285, 1992-1995
23. Montori, V. M.,&Guyatt, G. H. (2001). Intention-to-treat principle. Canadian Medical Association Journal, 165, 1339-1341
24. National Institute of Nursing Research. (2012). What is nursing research? Retrieved from http://www.ninr.nih.gov/
25. National Library ofMedicine, National Institutes of Health. (2012). PMC FAQs. PubMed Central (PMC). Retrieved from http://www .ncbi.nlm.nih.gov/pmc/ about/faq/#q1
26. Newell, D. J. (1992). Intention-to-treat analysis: Implications for quantitative and qualitative research. International Journal of Epidemiology, 21, 837-841
27. Olivo, S. A.,Macedo, L.G.,Gadotti, I. C., Fuentes, J., Stanton, T.,& Magee, D. J. (2008). Scales to assess the quality of randomized controlled trials:Asystematic review. Physical Therapy, 88, 156-175
28. Plint, A. C., Moher, D., Morrison, A., Schulz, K., Altman, D. G., Hill, C., & Gaboury, I. (2006). Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Medical Journal of Australia, 185, 263-267
29. Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. Journal of Clinical Epidemiology, 63, 834-840
30. Schulz, K. F., Chalmers, I., Hayes, R. J., & Altman, D. G. (1995). Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA, 273, 408-412
31. Smith, B. A., Lee, H-J., Lee, J. H., Choi, M., Jones, D. E., Bausell, R. B.,&Broome,M. E. (2008). Quality of reporting randomized controlled trials (RCTs) in the nursing literature: Application of the Consolidated Standards of Reporting Trials (CONSORT). Nursing Outlook, 56, 31.e3-37.e3
32. Underhill, M. L., Boucher, J., Roper, K., & Berry, D. L. (2012). Symptom management excellence initiative: Promoting evidencebased oncology nursing practice. Clinical Journal of Oncology Nursing, 16, 247-250
33. Van Zundert, J. (2007). Clinical research in interventional pain management techniques: The clinician's point of view. Pain Practice, 7, 221-229
34. Viera, A. J., & Bangdiwala, S. I. (2007). Eliminating bias in randomized controlled trials: Importance of allocation concealment and masking. Family Medicine, 39, 132-137
35. Viera, A. J., & Garrett, J. M. (2005). Understanding interobserver agreement: The kappa statistic. Family Medicine, 37, 360-363
36. Zhong, Y., Zhou, W., Jiang, H., Fan, T., Diao, X., Yang, H., I Mao, B. (2011). Quality of reporting of two-group parallel randomized controlled clinical trials ofmulti-herb formulae: A survey of reports indexed in the Science Citation Index Expanded. European Journal of Integrative Medicine, 3, e309Ye316